Clinical trial

Levosimendan Versus Dobutamine in Shock Patients

NCT00093301

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2004-10-01

PhasePHASE2 / PHASE3

Study timeline

Study start (unknown)2004-10-01Date precision: month

Registry last updated2005-06-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Cardiogenic Shockunresolved

Septic Shockunresolved

Interventions

LevosimendanDRUG

DobutamineDRUG · verified · RxNorm: dobutamine

Sponsors & collaborators

Wentworth Area Health Serviceslead sponsor

Abbottcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00093301 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.